Turning Point Therapeutics, Inc. (49) | Business Finance (8)
Browse by Subcategory
Recent Contracts
-
Underwriting Agreement, dated October 26, 2020, by and among Goldman Sachs & Co. LLC and SVB Leerink LLC, as representatives of the several underwriters named therein
(Filed With SEC on October 27, 2020)
-
Description of Common Stock
(Filed With SEC on March 18, 2020)
-
Fourth Amended and Restated Investor Rights Agreement, dated October 18, 2018, by and among the Registrant and certain of its securityholders
(Filed With SEC on March 21, 2019)
-
Underwriting Agreement, dated May 18, 2020, by and among Goldman Sachs & Co. LLC and SVB Leerink LLC, as representatives of the several underwriters named therein
(Filed With SEC on May 19, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on September 3, 2019)
-
Form of Underwriting Agreement
(Filed With SEC on April 8, 2019)
-
Form of Common Stock Certificate of the Registrant
(Filed With SEC on April 8, 2019)
-
Turning Point Therapeutics, Inc. 2019 Employee Stock Purchase Plan
(Filed With SEC on April 8, 2019)